Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,746	6,669	7,738	4,819	3,819	2,959
Trading Asset Securities	6,179	5,161	3,178	3,045	1,675	1,258
Cash & Short-Term Investments	10,925	11,830	10,916	7,863	5,494	4,217
Cash Growth	-6.16%	8.37%	38.82%	43.13%	30.28%	70.40%
Accounts Receivable	1,703	2,257	2,782	2,850	2,183	2,032
Other Receivables	24.87	12.5	14.99	17.2	11.98	10.33
Receivables	1,728	2,270	2,797	2,867	2,195	2,042
Inventory	338.55	569.09	490.08	391.48	375.59	278.42
Other Current Assets	46.4	32.6	32.5	54.23	58.34	38.13
Total Current Assets	13,038	14,702	14,235	11,177	8,123	6,576
Property, Plant & Equipment	2,576	2,706	2,922	2,856	3,034	3,141
Long-Term Investments	481.67	464.71	393.97	332.34	328.44	155.33
Goodwill	167.3	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	298.14	308.56	305.01	320.62	280.04	283.84
Long-Term Deferred Tax Assets	34.43	41.83	45.45	62.16	57.32	42.62
Long-Term Deferred Charges	2.41	2.38	11.91	3.87	13.19	23.67
Other Long-Term Assets	78.07	66.44	62.16	62.14	127.96	126.51
Total Assets	16,676	18,459	18,144	14,981	12,131	10,516
Accounts Payable	1,591	1,730	2,141	1,505	945.77	452.52
Accrued Expenses	161.55	254.87	246.62	350.39	242.7	207.74
Short-Term Debt	647.65	836.39	1,088	400	-	-
Current Portion of Long-Term Debt	-	-	-	-	627.55	-
Current Portion of Leases	1.1	1.07	1.06	0.44	1.55	-
Current Income Taxes Payable	46.69	99.77	182.62	106.09	43.71	69.64
Current Unearned Revenue	24.88	17.92	17.25	49.14	19.34	8.03
Other Current Liabilities	475.61	598.01	915.86	1,016	919.98	1,229
Total Current Liabilities	2,949	3,538	4,592	3,427	2,801	1,967
Long-Term Debt	-	-	-	-	-	602.58
Long-Term Leases	0.56	1.04	1.43	0.2	1.02	-
Long-Term Unearned Revenue	62.36	65.45	71.43	78.19	84.63	90.67
Long-Term Deferred Tax Liabilities	131.85	127.84	109.28	122.05	112.38	90.72
Other Long-Term Liabilities	0.45	0.53	0.82	1.06	1.35	1.67
Total Liabilities	3,144	3,733	4,775	3,629	3,000	2,753
Common Stock	452.69	452.69	452.74	452.74	436.27	436.26
Additional Paid-In Capital	4,014	4,012	3,999	3,984	3,148	3,114
Retained Earnings	9,150	10,345	9,010	6,998	5,431	4,112
Treasury Stock	-111.84	-108.57	-111.97	-97.18	-	-
Comprehensive Income & Other	-	-	-	-	100.81	100.87
Total Common Equity	13,504	14,702	13,349	11,337	9,117	7,763
Minority Interest	27.62	24.57	19.42	15.14	14.17	-
Shareholders' Equity	13,532	14,726	13,369	11,352	9,131	7,763
Total Liabilities & Equity	16,676	18,459	18,144	14,981	12,131	10,516
Total Debt	649.31	838.5	1,090	400.65	630.12	602.58
Net Cash (Debt)	10,276	10,992	9,826	7,463	4,864	3,615
Net Cash Growth	-0.13%	11.86%	31.67%	53.43%	34.56%	90.37%
Net Cash Per Share	11.17	11.98	10.72	8.22	5.40	4.33
Filing Date Shares Outstanding	939.98	912.53	921.81	921.82	888.27	888.26
Total Common Shares Outstanding	939.98	912.53	921.81	921.82	888.27	888.26
Working Capital	10,090	11,164	9,644	7,749	5,322	4,609
Book Value Per Share	14.37	16.11	14.48	12.30	10.26	8.74
Tangible Book Value	13,039	14,226	12,877	10,849	8,670	7,312
Tangible Book Value Per Share	13.87	15.59	13.97	11.77	9.76	8.23
Buildings	2,951	2,953	2,911	2,455	2,473	2,362
Machinery	1,736	1,728	1,685	1,644	1,566	1,488
Construction In Progress	152.12	156.63	186.98	352.15	322.17	364.89

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.